Mail

Canada markets close in 6 hours 21 minutes

S&P/TSX
21,692.99
-95.49(-0.44%)
S&P 500
5,457.09
-12.21(-0.22%)
DOW
38,983.78
-128.38(-0.33%)
CAD/USD
0.7299
-0.0024(-0.32%)
CRUDE OIL
80.87
+0.04(+0.05%)
Bitcoin CAD
84,481.73
+799.03(+0.95%)

COUCHE-TARD TAPS ALEX MILLER TO SUCCEED CEO BRIAN HANNASCH

Miller, who's currently chief operating officer, will take over from September 6

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real Time Price. Currency in INR

Add to watchlist

1,200.50

-18.00

(-1.48%)

At close: 03:47PM IST

Currency in INR

Valuation Measures⁴

Market Cap (intraday)	712.71B
Enterprise Value	713.26B
Trailing P/E	22.50
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.49
Price/Book (mrq)	2.39
Enterprise Value/Revenue	2.48
Enterprise Value/EBITDA	11.52

Trading Information

Stock Price History

Beta (5Y Monthly)	0.51
52-Week Change ³	65.16%
S&P500 52-Week Change ³	24.96%
52 Week High ³	1,292.15
52 Week Low ³	710.95
50-Day Moving Average ³	1,181.39
200-Day Moving Average ³	1,047.23

Share Statistics

Avg Vol (3 month) ³	49.89k
Avg Vol (10 day) ³	21.77k
Shares Outstanding ⁵	585.17M
Implied Shares Outstanding ⁶	586.32M
Float ⁸	280.83M
% Held by Insiders ¹	52.03%
% Held by Institutions ¹	32.40%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	4.5
Forward Annual Dividend Yield ⁴	0.37%
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	0.69
Payout Ratio ⁴	8.31%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	Feb 20, 2024
Last Split Factor ²	2:1
Last Split Date ³	Jul 20, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends	Mar 31, 2024
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	10.94%
Operating Margin (ttm)	17.58%

Management Effectiveness

Return on Assets (ttm)	6.36%
Return on Equity (ttm)	11.18%

Income Statement

Revenue (ttm)	290.02B
Revenue Per Share (ttm)	495.04
Quarterly Revenue Growth (yoy)	17.10%
Gross Profit (ttm)	N/A
EBITDA	58.43B
Net Income Avi to Common (ttm)	31.73B
Diluted EPS (ttm)	54.10
Quarterly Earnings Growth (yoy)	79.50%

Balance Sheet

Total Cash (mrq)	63.29B
Total Cash Per Share (mrq)	108.02
Total Debt (mrq)	66.48B
Total Debt/Equity (mrq)	22.27%
Current Ratio (mrq)	1.98
Book Value Per Share (mrq)	509.34

Cash Flow Statement

Operating Cash Flow (ttm)	24.35B
Levered Free Cash Flow (ttm)	-12.93B